Jianlin Wang

ORCID: 0000-0001-8322-9529
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Advanced Nanomaterials in Catalysis
  • Erythrocyte Function and Pathophysiology

Shanxi Medical University
2023

Triple-negative breast cancer (TNBC) was closely related to high metastatic risk and mortality has not yet found a targeted receptor for therapy. Cancer immunotherapy, especially photoimmunotherapy, shows promising potential in TNBC treatment because of great spatiotemporal controllability non-trauma. However, the therapeutic effectiveness limited by insufficient tumor antigen generation immunosuppressive microenvironment.We report on design cerium oxide (CeO2) end-deposited gold nanorods...

10.3390/pharmaceutics15041309 article EN cc-by Pharmaceutics 2023-04-21
Coming Soon ...